BUKU BASA INGGRIS KAKAIT KARO «GILEAD»
Temukaké kagunané saka
Gilead ing pilihan bibliografi iki. Buku kang kakait dening
Gilead lan pethikan cekak kang padha kanggo nyediyakaké panggunané ing sastra Basa Inggris.
Een bejaarde dominee schrijft in 1856 aan zijn dan 7-jarige zoon over vroeger en heden.
This is also the tale of another remarkable vision--not a corporeal vision of God but the vision of life as a wondrously strange creation.
You might not share its faith, but it is difficult not to be awed moved and ultimately humbled by the spiritual effulgence that lights up the novel from within' Neel Mukherjee, The Times 'Writing of this quality, with an authority as ...
Mr. McDonagh's great strength is that he combines a love of traditional storytelling with the savage ironic humour of the modern generation.
5
A Balm for
Gilead: Meditations on Spirituality and the ...
Health care professionals -- and anyone else involved with the care of the sick and dying -- will find this series of meditations both inspiring and instructive.
Through the story told by Marilynne Robinson in her novel Gilead (Farrar, Straus and Giroux, 2004), Harken and Moses take readers on a journey to discover the gifts of their own life stories.
Amy Lignitz Harken, Lee Hull Moses,
2005
7
Israeli-Palestinian Peace Negotiations, 1999-2001: Within Reach
Written by Gilead Sher, the Israeli Chief of Staff during the tumultuous 1999-2000 peace negotiations, the book provides a fast paced description and analysis of the Israel-Palestine conflict.
Linked initially by the love affair of two of the sons, Jonathan and Tom, the families' relationships evolve into an intriguing web.The novel traces the connections between the two families over three and a half decades.
With his faithful retainer Fithvael at his side, the doom-laden Gilead battles corrupt humans, beastmen, warriors of the Dark Gods and more in this collection of action-packed tales.
Dan Abnett, Nik Vincent,
2013
10
No Balm in
Gilead: A Personal Retrospective of Mandate Days ...
This book is a rare personal record by a Canadian of the last fifteen years of the British mandate in Palestine.
BABAGAN WARTA KANG NGLEBOKAKÉ ARAN «GILEAD»
Weruhi yèn pawarta nasional lan internasional wis ngomongaké lan kepriyé aran
Gilead digunakaké ing babagan warta iki.
Trade of the Day: No. 1 Biotech Pick GILD on Sale
Gilead Sciences, Inc. (GILD) — I last covered GILD stock in the Trade of the Day on June 16. Since then, shares have fallen nearly 4%. «Investorplace.com, Jul 15»
Gilead: $1000-per-pill hepatitis drug overtaken by even pricier …
Sovaldi, last year's wonder drug, has been pushed aside by a successor called Harvoni, made by the same company, Foster City's Gilead ... «San Jose Mercury News, Jul 15»
Gilead Sciences, Inc. (GILD) Shares To Recover Soon
Gilead Sciences, Inc. (NASDAQ:GILD) has had a bad month so far. Despite the company stock reaching its all-time high last month, and with ... «Bidness ETC, Jul 15»
Gilead Sciences, Inc. Vs. GlaxoSmithKline plc (ADR) In The HIV …
Gilead Sciences, Inc. (NASDAQ:GILD), the undisputed leader of the fast-expanding Hepatitis C drugs market, is headed for dominating the HIV ... «Bidness ETC, Jul 15»
Biotech Stocks Buzz - Gilead Sciences, Inc. (NASDAQ:GILD), Idera …
Gilead Sciences, Inc. (NASDAQ:GILD) rose +0.37% to end last trading session at $113.36. The company, on June 03, 2015, released that the ... «Wall Street Observer, Jul 15»
Notable Session Mover: Gilead Sciences, Inc. (NASDAQ:GILD)
A notable mover in today's trading session is Gilead Sciences, Inc. (NASDAQ:GILD) as the stock opened the most recent session at 115.00 and ... «Vanguard Tribune, Jul 15»
What Is the Potential Impact of Gilead's Harvoni Launching in Japan?
Following its approval for use in hepatitis C genotype 1 patients last fall, Gilead Sciences' (NASDAQ:GILD) Harvoni became an instant success, ... «Motley Fool, Jul 15»
Gilead Sciences: Four Reasons For Optimism
RBC's Michael Yee and Adnan Butt highlight four reasons to remain positive on Gilead Sciences (GILD) despite decelerating prescriptions and ... «Barron's, Jul 15»
Glaxo's HIV unit ViiV aims to steal share from Gilead before patents …
Meds from ViiV and market leader Gilead Sciences ($GILD) may run out of room for improvement short of an actual cure, and current therapies ... «FiercePharma, Jul 15»
Premarket Biotech Digest: Gilead's Patent Expiry, Galmed Interview …
Some readers have asked for my opinion on Gilead's (NASDAQ:GILD) patent expiry. Atripla expires in 2021, Complera in 2023, sofosbuvir, ... «Seeking Alpha, Jul 15»